These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25782638)

  • 1. Phenotype-genotype correlations for clinical variants caused by CYLD mutations.
    Nagy N; Farkas K; Kemény L; Széll M
    Eur J Med Genet; 2015 May; 58(5):271-8. PubMed ID: 25782638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel and recurrent germline and somatic mutations in a cohort of 67 patients from 48 families with Brooke-Spiegler syndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens.
    Grossmann P; Vanecek T; Steiner P; Kacerovska D; Spagnolo DV; Cribier B; Rose C; Vazmitel M; Carlson JA; Emberger M; Martinek P; Pearce RL; Pearn J; Michal M; Kazakov DV
    Am J Dermatopathol; 2013 Feb; 35(1):34-44. PubMed ID: 23249834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CYLD p.R758X worldwide recurrent nonsense mutation detected in patients with multiple familial trichoepithelioma type 1, Brooke-Spiegler syndrome and familial cylindromatosis represents a mutational hotspot in the gene.
    Farkas K; Deák BK; Sánchez LC; Martínez AM; Corell JJ; Botella AM; Benito GM; López RR; Vanecek T; Kazakov DV; Kromosoeto JN; van den Ouweland AM; Varga J; Széll M; Nagy N
    BMC Genet; 2016 Feb; 17():36. PubMed ID: 26861065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large germline deletions of the CYLD gene in patients with Brooke-Spiegler syndrome and multiple familial trichoepithelioma.
    Vanecek T; Halbhuber Z; Kacerovska D; Martinek P; Sedivcova M; Carr RA; Slouka D; Michal M; Kazakov DV
    Am J Dermatopathol; 2014 Nov; 36(11):868-74. PubMed ID: 25347032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYLD mutations in familial skin appendage tumours.
    Saggar S; Chernoff KA; Lodha S; Horev L; Kohl S; Honjo RS; Brandt HR; Hartmann K; Celebi JT
    J Med Genet; 2008 May; 45(5):298-302. PubMed ID: 18234730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of Brooke-Spiegler syndrome with a novel mutation in the CYLD gene in a patient with aggressive non-Hodgkin's lymphoma.
    Hunstig F; Schulz S; Nieten I; Froster U; Boltze C; Schliemann S; Hochhaus A; La Rosée P
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):845-8. PubMed ID: 26660106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype variability in tumor disorders of the skin appendages associated with mutations in the CYLD gene.
    Parren LJMT; Giehl K; van Geel M; Frank J
    Arch Dermatol Res; 2018 Sep; 310(7):599-606. PubMed ID: 29974194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation.
    Bowen S; Gill M; Lee DA; Fisher G; Geronemus RG; Vazquez ME; Celebi JT
    J Invest Dermatol; 2005 May; 124(5):919-20. PubMed ID: 15854031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse phenotype of Brooke-Spiegler syndrome associated with a nonsense mutation in the CYLD tumor suppressor gene.
    Zhang G; Huang Y; Yan K; Li W; Fan X; Liang Y; Sun L; Li H; Zhang S; Gao M; Du W; Yang S; Liu J; Zhang X
    Exp Dermatol; 2006 Dec; 15(12):966-70. PubMed ID: 17083363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel CYLD germline mutation in Brooke-Spiegler syndrome.
    Guardoli D; Argenziano G; Ponti G; Nasti S; Zalaudek I; Moscarella E; Lallas A; Piana S; Specchio F; Martinuzzi C; Raucci M; Pellacani G; Longo C
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):457-62. PubMed ID: 25131725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel missense mutation of the CYLD gene identified in a Hungarian family with Brooke-Spiegler syndrome.
    Nagy N; Farkas K; Kinyo A; Nemeth IB; Kis E; Varga J; Bata-Csorgo Z; Kemeny L; Szell M
    Exp Dermatol; 2012 Dec; 21(12):967-9. PubMed ID: 23171463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel missense mutation in CYLD in a family with Brooke-Spiegler syndrome.
    Hu G; Onder M; Gill M; Aksakal B; Oztas M; Gürer MA; Celebi JT
    J Invest Dermatol; 2003 Oct; 121(4):732-4. PubMed ID: 14632188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brooke-Spiegler Syndrome and Phenotypic Variants: An Update.
    Kazakov DV
    Head Neck Pathol; 2016 Jun; 10(2):125-30. PubMed ID: 26971504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of Three Novel Germline CYLD Mutations in Unrelated Patients with Brooke-Spiegler Syndrome, Including Classic Phenotype, Multiple Familial Trichoepitheliomas and Malignant Transformation.
    Tantcheva-Poór I; Vanecek T; Lurati MC; Rychly B; Kempf W; Michal M; Kazakov DV
    Dermatology; 2016; 232(1):30-7. PubMed ID: 26329847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYLD mutations underlie Brooke-Spiegler, familial cylindromatosis, and multiple familial trichoepithelioma syndromes.
    Young AL; Kellermayer R; Szigeti R; Tészás A; Azmi S; Celebi JT
    Clin Genet; 2006 Sep; 70(3):246-9. PubMed ID: 16922728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild phenotype of familial cylindromatosis associated with an R758X nonsense mutation in the CYLD tumour suppressor gene.
    Oiso N; Mizuno N; Fukai K; Nakagawa K; Ishii M
    Br J Dermatol; 2004 Nov; 151(5):1084-6. PubMed ID: 15541090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes.
    Ponti G; Nasti S; Losi L; Pastorino L; Pollio A; Benassi L; Giudice S; Bertazzoni G; Veratti E; Azzoni P; Bianchi Scarrà G; Seidenari S
    J Cutan Pathol; 2012 Mar; 39(3):366-71. PubMed ID: 22077640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity.
    Almeida S; Maillard C; Itin P; Hohl D; Huber M
    J Invest Dermatol; 2008 Mar; 128(3):587-93. PubMed ID: 17851586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages.
    Poblete Gutiérrez P; Eggermann T; Höller D; Jugert FK; Beermann T; Grussendorf-Conen EI; Zerres K; Merk HF; Frank J
    J Invest Dermatol; 2002 Aug; 119(2):527-31. PubMed ID: 12190880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling.
    Blake PW; Toro JR
    Hum Mutat; 2009 Jul; 30(7):1025-36. PubMed ID: 19462465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.